Transferrin receptor facilitates TGF-β and BMP signaling activation to control craniofacial morphogenesis

Cell Death and Disease

Volumn 7, Issue 6, 2016, Pages

  Lei, R ^a,b   Zhang, K ^a,c   Liu, K ^c   Shao, X ^c   Ding, Z ^c   Wang, F ^d   Hong, Y ^e   Zhu, M ^b   Li, H ^a,b,c,f  

^a SICHUAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f SIP Biobay   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; TRANSFERRIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ANATOMICAL CONCEPTS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CLEFT PALATE; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; CRANIOFACIAL MORPHOLOGY; DISEASE SEVERITY; HISTOLOGY; MICROGNATHIA; MOUSE; NEURAL CREST CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SIGNAL TRANSDUCTION; ABNORMALITIES; ANIMAL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MOTION; CHONDROGENESIS; GENE DELETION; GENETICS; MANDIBLE; METABOLISM; MORPHOGENESIS; MUTATION; NEURAL CREST; PATHOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CHONDROGENESIS; CLEFT PALATE; CRANIOFACIAL ABNORMALITIES; GENE DELETION; MANDIBLE; MICE; MORPHOGENESIS; MUTATION; NEURAL CREST; OSTEOGENESIS; RECEPTORS, TRANSFERRIN; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 85011825547     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.170     Document Type: Article

References (52)

1. Farlie PG, McKeown SJ, Newgreen DF. The neural crest: basic biology and clinical relationships in the craniofacial and enteric nervous systems. Birth Defects Res C Embryo Today 2004; 72: 173–189.
2. Gammill LS, Bronner-Fraser M. Neural crest specification: migrating into genomics. Nat Rev Neurosci 2003; 4: 795–805.
3. Knecht AK, Bronner-Fraser M. Induction of the neural crest: a multigene process. Nat Rev Genet 2002; 3: 453–461.
4. Mayor R, Theveneau E. The neural crest. Development 2013; 140: 2247–2251.
5. Chai Y, Maxson RE Jr. Recent advances in craniofacial morphogenesis. Dev Dyn 2006; 235: 2353–2375.
6. Izumi K, Konczal LL, Mitchell AL, Jones MC. Underlying genetic diagnosis of Pierre Robin sequence: retrospective chart review at two children's hospitals and a systematic literature review. J Pediatr 2012; 160: 645–650 e642.
7. Ricks JE, Ryder VM, Bridgewater �LC, Schaalje B, Seegmiller RE. Altered mandibular development precedes the time of palate closure in mice homozygous for disproportionate micromelia: an oral clefting model supporting the Pierre-Robin sequence. Teratology 2002; 65: 116–120.
8. Robin P. Glossoptosis due to atresia and hypotrophy of the mandible. Am J Dis Child 1934; 48: 541–547.
9. Printzlau A, Andersen M. Pierre Robin sequence in Denmark: a retrospective population-based epidemiological study. Cleft Palate Craniofac J 2004; 41: 47–52.
10. Sheffield LJ, Reiss JA, Strohm K, Gilding M. A genetic follow-up study �of 64 patients with the Pierre Robin complex. Am J Med Genet 1987; 28: 25–36.
11. Melkoniemi M, Koillinen H, Mannikko M, Warman ML, Pihlajamaa T, Kaariainen H et al. Collagen XI sequence variations in nonsyndromic cleft palate, Robin sequence and micrognathia. Eur J Hum Genet 2003; 11: 265–270.
12. Britanova O, Depew MJ, Schwark M, Thomas BL, Miletich I, Sharpe P et al.. Satb2 haploinsufficiency phenocopies 2q32-q33 deletions, whereas �loss suggests a fundamental role in the coordination of jaw development. Am J Hum Genet 2006; 79: 668–678.
13. Jakobsen LP, Ullmann R, Christensen SB, Jensen KE, Molsted K, Henriksen KF et al. Pierre Robin sequence may be caused by dysregulation of SOX9 and KCNJ2. J Med Genet 2007; 44: 381–386.
14. Benko S, Fantes JA, Amiel J, Kleinjan DJ, Thomas S, Ramsay J et al. Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat Genet 2009; 41: 359–364.
15. Sahoo T, Theisen A, Sanchez-Lara PA, Marble M, Schweitzer DN, Torchia BS et al. Microdeletion 20p12.3 involving BMP2 contributes to syndromic forms of cleft palate. Am J Med Genet A 2011; 155 A: 1646–1653.
16. Bush JO, Jiang R. Palatogenesis: morphogenetic and molecular mechanisms of secondary palate development. Development 2012; 139: 231–243.
17. Gendron-Maguire M, Mallo M, Zhang M, Gridley T. Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest. Cell 1993; 75: 1317–1331.
18. Miettinen PJ, Chin JR, Shum L, Slavkin HC, Shuler CF, Derynck R et al. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat Genet 1999; 22: 69–73.
19. Dudas M, Sridurongrit S, Nagy A, Okazaki K, Kaartinen V. Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech Dev 2004; 121: 173–182.
20. Murray SA, Oram KF, Gridley T. Multiple functions of Snail family genes during palate development in mice. Development 2007; 134: 1789–1797.
21. Bjork BC, Turbe-Doan A, Prysak M, Herron BJ, Beier DR. Prdm16 is required for normal palatogenesis in mice. Hum Mol Genet 2010; 19: 774–789.
22. Stewart K, Uetani N, Hendriks W, Tremblay ML, Bouchard M. Inactivation of LAR family phosphatase genes Ptprs and Ptprf causes craniofacial malformations resembling Pierre-Robin sequence. Development 2013; 140: 3413–3422.
23. Aisen P. Transferrin receptor 1. Int J Biochem Cell Biol 2004; 36: 2137–2143.
24. Cheng Y, Zak O, Aisen P, Harrison SC, Walz T. Structure of the human transferrin receptor-transferrin complex. Cell 2004; 116: 565–576.
25. Brewer S, Feng W, Huang J, Sullivan S, Williams T. Wnt1-Cre-mediated deletion of AP-2alpha causes multiple neural crest-related defects. Dev Biol 2004; 267: 135–152.
26. Mitchell PJ, Timmons PM, Hebert JM, Rigby PW, Tjian R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev 1991; 5: 105–119.
27. Levy JE, Jin O, Fujiwara Y, Kuo F, Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 1999; 21: 396–399.
28. Danielian PS, Muccino D, Rowitch DH, Michael SK, McMahon AP. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 1998; 8: 1323–1326.
29. Chen AC, Donovan A, Ned-Sykes R, Andrews NC. Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis. Proc Natl Acad Sci USA 2015; 112: 11714–11719.
30. Frommer J, Margolies MR. Contribution of Meckel's cartilage to ossification of the mandible in mice. J Dent Res 1971; 50: 1260–1267.
31. Liu W, Sun X, Braut A, Mishina Y, Behringer RR, Mina M et al. Distinct functions for Bmp signaling in lip and palate fusion in mice. Development 2005; 132: 1453–1461.
32. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997; 124: 2659–2670.
33. Ito Y, Yeo JY, Chytil A, Han J, Bringas P Jr, Nakajima A et al. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 2003; 130: 5269–5280.
34. Liu W, Selever J, Murali D, Sun X, Brugger SM, Ma L et al. Threshold-specific requirements for Bmp4 in mandibular development. Dev Biol 2005; 283: 282–293.
35. Dudas M, Kim J, Li WY, Nagy A, Larsson J, Karlsson S et al. Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion. Dev Biol 2006; 296: 298–314.
36. Ko SO, Chung IH, Xu X, Oka SJ, Zhao H, Cho ES et al. Smad4 is required to regulate the fate of cranial neural crest cells. Dev Biol 2007; 312: 435–447.
37. Oka K, Oka S, Sasaki T, Ito Y, Bringas P, Nonaka K et al. The role of TGF-beta signaling in regulating chondrogenesis and osteogenesis during mandibular development. Dev Biol 2007, 303: 391–404.
38. Hartung A, Bitton-Worms K, Rechtman MM, Wenzel V, Boergermann JH, Hassel S et al. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol 2006; 26: 7791–7805.
39. Satow R, Kurisaki A, Chan TC, Hamazaki TS, Asashima M. Dullard promotes degradation and dephosphorylation of BMP receptors and is required for neural induction. Dev Cell 2006; 11: 763–774.
40. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 2003; 5: 410–421.
41. Yao D, Ehrlich M, Henis YI, Leof EB. Transforming growth factor-beta receptors interact with AP2 by direct binding to beta2 subunit. Mol Biol Cell 2002; 13: 4001–4012.
42. Bragdon B, Thinakaran S, Bonor J, Underhill TM, Petersen NO, Nohe A. FRETreveals novel protein-receptor interaction of bone morphogenetic proteins receptors and adaptor protein 2 at the cell surface. Biophys J 2009; 97: 1428–1435.
43. Iacopetta BJ, Rothenberger S, Kuhn LC. A role for the �cytoplasmic domain in transferrin receptor sorting and coated pit formation during endocytosis. Cell 1988; 54: 485–489.
44. Miller K, Shipman M, Trowbridge IS, Hopkins CR. Transferrin receptors promote the formation of clathrin lattices. Cell 1991; 65: 621–632.
45. Liu AP, Aguet F, Danuser G, Schmid SL. Local clustering of transferrin receptors promotes clathrin-coated pit initiation. J Cell Biol 2010; 191: 1381–1393.
46. Ohno H, Stewart J, Fournier MC, Bosshart H, Rhee I, Miyatake S et al. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 1995; 269: 1872–1875.
47. Mark M, Lufkin T, Vonesch JL, Ruberte E, Olivo JC, Dolle P et al. Two rhombomeres are altered in Hoxa-1 mutant mice. Development 1993; 119: 319–338.
48. Taya Y, O'Kane S, Ferguson MW. Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development 1999; 126: 3869–3879.
49. Iwata J, Hosokawa R, Sanchez-Lara PA, Urata M, Slavkin H, Chai Y. Transforming growth factor-beta regulates basal transcriptional regulatory machinery to control cell proliferation and differentiation in cranial neural crest-derived osteoprogenitor cells. J Biol Chem 2010; 285: 4975–4982.
50. Zhou Z, Xie J, Lee D, Liu Y, Jung J, Zhou L et al. Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation. Dev Cell 2010; 19: 90–102.
51. Tataria M, Quarto N, Longaker MT, Sylvester KG. Absence of the p53 tumor suppressor gene promotes osteogenesis in mesenchymal stem cells. J Pediatr Surg 2006; 41: 624–632 discussion 624-632.
52. Wu JY, Aarnisalo P, Bastepe M, Sinha P, Fulzele K, Selig MK et al. Gsalpha enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice. J Clin Invest 2011; 121: 3492–3504.